Fintop

Butenafine HCl INN

Composition : Butenafine HCl INN 1%.

Indication : Butenafine cream is indicated for the topical treatment of following superficial dermatophytes: tinea pedis (athletes foot), tinea corporis (ringworm), tinea cruris (jockitch) due to M. furfur, E. floccosum, T. mentagrophytes, T. rubrum, T. tonsurans.

Dosage and administration : Patients with tinea (pityriasis) versicolor should apply butenafine once daily for two weeks. In the treatment of interdigital tinea pedis butenafine should be applied twice daily for 7 days or once daily for 4 weeks. Patients with tinea corporis or tinea cruris should apply butenafine once daily for two weeks. Or, as directed by the registered physician.

Use in pregnancy and lactation : No adequate and well controlled studies that have been conducted with topically applied butenafine in pregnant women. This drug should be used during pregnancy only if clearly needed. It is not known if butenafine HCl is excreted in human milk, caution should be exercised in prescribing butenafine Cream, to a nursing woman. Pregnancy Category C.

Packing : Fintop Cream : 10gm in a tube.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2024 Designed and Developed by ATI Limited.